Effect of hyperoxia on human macrophage cytokine response

Respiratory Medicine

Volumn 92, Issue 7, 1998, Pages 951-960

  Desmarquest, P ^a   Chadelat, K ^a   Corroyer, S ^a   Cazals, V ^a   Clement, A ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HYPEROXIA; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; MACROPHAGE FUNCTION; OXIDATIVE STRESS; PRIORITY JOURNAL; TIME;

EID: 0031660148     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90195-0     Document Type: Article

References (43)

1. Doelman CJA, Bast A. Oxygen radicals in lung pathology. Free Radic Biol Med 1990; 9: 381-400.
2. Freeman BA, Crapo JD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem 1981; 256: 10986-10992.
3. Harris DE. Regulation of antioxidant enzymes. FASEB J 1992; 6: 2675-2683.
4. Crapo JD. Morphologic changes in pulmonary oxygen toxicity. Ann Rev Physiol 1986; 48: 721-731.
5. Bast A, Haenen GMM, Doelman CJA. Oxidants and antioxidants: state of the art. Am J Med 1991; 91 (Suppl. 3C): 2S-13S.
6. Elias JA, Freundlich B, Kern JA, Rosenbloom J. Cytokine networks in regulation of inflammation and fibrosis in the lung. Chest 1990; 97: 1439-1445.
7. Kelley J. Cytokines of the lung. Am Rev Respir Dis 1990; 141: 765-788.
8. Rochester CL, Elias JA. Cytokines and cytokine networking in the pathogenesis of interstitial and fibrotic lung disorders. Semin Resp Med 1993; 14: 389-416.
9. Tessier V, Chadelat K, Baculard A, Housset B, Clement A. Bronchoalveolar lavage in children: a controlled study of differential cytology and cytokine expression profiles by alveolar cells in pediatric sarcoidosis. Chest 1996; 109: 1430-1438.
10. Clement A, Chadelat K, Masliah J. A controlled study of oxygen release by alveolar macrophages from children with interstitial lung disease. Am Rev Respir Dis 1987; 136: 424-428.
11. Chadelat K, Baculard A, Grimfeld A. Pulmonary sarcoidosis in children: serial evaluation of bronchoalveolar lavage cells during corticosteroid treatment. Pediatr Pulmonol 1993; 16: 41-47.
12. Bellon T, Lopez-Rodriguez C, Rubio MA, Jochems G, Bernabeu C, Corbi AL. Regulated expression of p150, 95 (CD11c/CD18) and VLA-4 (CD49d/CD29; α4.β1) integrins during myeloid cell differentiation. Eur J Immunol 1994; 24: 41-47.
13. Konikova E, Babusikova O, Kusenda J, Glasova M. Detection of cytoplasmic and surface membrane markers in cells of some human hematopoietic cell lines. Neoplasma 1992; 39: 337-342.
14. Corroyer S, Maitre B, Cazals S, Clement A. Altered regulation of G1 cyclin in oxidant-induced growth arrest of lung alveolar epithelial cells. J Biol Chem 1996; 71: 25117-25125.
15. Adolff CH, Golden JA, Kennedy PW. Polymerase chain reaction amplification of messages for growth factors in cells from human bronchoalveolar lavage fluids. Inflammation 1991; 15: 259-268.
16. Mullis K, Faloona F. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Meth Enzymol 1987; 155: 335-368.
17. Clement A, Campisi J, Farmer SR, Brody JS. Constitutive expression of growth-related mRNAs in proliferating and nonproliferating lung epithelial cells in primary culture: evidence for growth-dependent translational control. Proc Natl Acad Sci USA 1990; 87: 318-322.
18. Aggarwal BB, Kohr WH. Human tumor necrosis factor. Meth Enzymol 1985; 116: 448-456.
19. Standiford TJ, Kunkel SL, Kasahara K, Milia MJ, Rolfe MW, Strieter RM. Interleukin-8 gene expression from human alveolar macrophages: the role of adherence. Am J Respir Cell Mol Biol 1991; 5: 579-585.
20. Hass R, Lonnemann G, Männel D et al. Regulation of TNFalpha and IL-6 synthesis in differentiating human monoblastoid leukemic U937 cells. Leuk Res 1991; 15: 327-339.
21. Deaton PR, McKellar CT, Culbreth R, Veal CF, Cooper JAD. Hyperoxia stimulates interleukin-8 release from alveolar macrophages and U-937 cells: attenuation by dexamethasone. Am J Physiol 1994; 267: L187-L192.
22. Öberg F, Nilsson K. Differentiation and activation associated expression of IL-6 and IL-6 receptors in U-937 monocytic cells: relationship to the expression of CD14. Growth Factors 1992; 7: 85-96.
23. O'Brien-Ladner AR, Nelson ME, Cowley BD, Bailey K, Wesselius LJ. Hyperoxia amplifies TNFalpha production in LPS-stimulated human alveolar macrophages. Am J Respir Cell Mol Biol 1995; 12: 275-279.
24. 2 tolerance. Am J Physiol 1992; 263: L22-L26.
25. White CW. Cytokines increase rat lung antioxidant enzymes during exposure to hyperoxia. J Appl Physiol 1989; 66: 1003-1007.
26. White CW, Ghezzi P. Protection against pulmonary oxygen toxicity by interleukin-1 and tumor necrosis factor: role of antioxidant enzymes and effect of cyclooxygenase inhibitors. Biotherapy 1989; 1: 361-367.
27. Wong GHW, Goeddel DV. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 1988; 242: 941-944.
28. Tsan MF, White JE, Santana TA, Lee CY. Tracheal insufflation of tumor necrosis factor protects rats against oxygen toxicity. J Appl Physiol 1990; 68: 1211-1219.
29. Tsan MF, Lee CY, White JE. Interleukin-1 protects rats against oxygen toxicity. J Appl Physiol 1991; 71: 688-697.
30. Mikawa K, Nishina K, Maekawa N, Obara H. Attenuation of hyperoxic lung injury in rabbits with superoxide dismutase: effects on inflammatory mediators. Acta Anaesthesiol Scand 1995; 39: 317-322.
31. Sauty A, Mauel J, Philippeaux MM, Leuenberger P. Cytostatic activity of alveolar macrophages from smokers and nonsmokers: role of interleukin-1β, interleukin-6, and tumor necrosis factor-α. Am J Respir Cell Mol Biol 1994; 11: 631-637.
32. Becker S, Madden MC, Newman SL, Devlin RB, Koren HS. Modulation of human alveolar macrophage properties by ozone exposure in vitro. Toxicol Appl Pharmacol 1991; 110: 403-415.
33. Inamoto Y, Okuno F, Saito K et al. Effect of hyperbaric oxygenation on macrophage function in mice. Biochem Biophys Res Comm 1991; 179: 886-891.
34. McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994; 150: 696-703.
35. DeForge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, Remick DG. Regulation of interleukin-8 gene expression by oxidant stress J Biol Chem 1993; 268: 25568-25576.
36. Hentze MW, Rouault TA, Harford JB, Klausner RD. Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction. Science 1989; 244: 357-359.
37. Mattia E, den Blaauwen J, Ashwell G, van Renswoude J. Multiple post-transcriptional regulatory mechanisms in ferritin gene expression. Proc Natl Acad Sci USA 1989; 86: 1801-1805.
38. Baeuerle PA. The inductible transcription activator NF-κB: regulation by distinct protein subunits. Biochim Biophys Acta 1991; 1072: 63-80.
39. Pahl H, Baeuerle PA. Oxygen and the control of gene expression. BioEssays 1994; 16: 497-502.
40. Schenk H, Klein M, Erdbrügger W, Dröge W, Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc Natl Acad Sci USA 1994; 91: 1672-1676.
41. Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell 1996; 87: 13-20.
42. Anderson MT, Staal FJT, Gitler C, Herzenberg LA, Herzenberg LA. Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc Natl Acad Sci USA 1994; 91: 11527-11531.
43. Li Y, Zhang W, Mantell LL, Kazzaz JA, Fein AM, Horowitz S. Nuclear factor-κB is activated by hyperoxia but does not protect from cell death. J Biol Chem 1997; 272: 20646-20649.